The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression

por Pascale, Mariarosa, Azinwi, Che Ngwa, Marongiu, Barbara, Pesce, Gianfranco, Stoffel, Flavio, Roggero, Enrico
Publicado 2017

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients

por Pascale, Mariarosa, Aversa, Cinzia, Barbazza, Renzo, Marongiu, Barbara, Siracusano, Salvatore, Stoffel, Flavio, Sulfaro, Sando, Roggero, Enrico, Bonin, Serena, Stanta, Giorgio
Publicado 2016

Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

por Bolis, Marco, Bossi, Daniela, Vallerga, Arianna, Ceserani, Valentina, Cavalli, Manuela, Impellizzieri, Daniela, Di Rito, Laura, Zoni, Eugenio, Mosole, Simone, Elia, Angela Rita, Rinaldi, Andrea, Pereira Mestre, Ricardo, D’Antonio, Eugenia, Ferrari, Matteo, Stoffel, Flavio, Jermini, Fernando, Gillessen, Silke, Bubendorf, Lukas, Schraml, Peter, Calcinotto, Arianna, Corey, Eva, Moch, Holger, Spahn, Martin, Thalmann, George, Kruithof-de Julio, Marianna, Rubin, Mark A., Theurillat, Jean-Philippe P.
Publicado 2021